Provided by Tiger Trade Technology Pte. Ltd.

AbCellera Biologics

10.61
-0.7100-6.27%
Pre-market: 10.990.3800+3.58%08:50 EDT
Volume:6.59M
Turnover:70.23M
Market Cap:3.44B
PE:-19.45
High:11.01
Open:10.97
Low:10.44
Close:11.32
52wk High:12.15
52wk Low:2.75
Shares:324.00M
Float Shares:221.00M
Volume Ratio:0.88
T/O Rate:2.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5455
EPS(LYR):-0.4902
ROE:-17.30%
ROA:-10.39%
PB:3.84
PE(LYR):-21.65

Loading ...

Major Insider Move Signals Growing Confidence in AbCellera Biologics

TIPRANKS
·
10 hours ago

Abcellera Director Michael R. Hayden Reports $570,442 Common Share Purchase

Reuters
·
15 hours ago

AbCellera Biologics call volume above normal and directionally bullish

TIPRANKS
·
Aug 20

Insider Confidence Surge: Director Makes Bold Move on AbCellera Biologics

TIPRANKS
·
Aug 19

Abcellera Director John S. Montalbano Acquires Common Shares Worth $110,300

Reuters
·
Aug 19

AbCellera Biologics (ABCL) Gets a Buy from BMO Capital

TIPRANKS
·
Aug 18

Abcellera Director Michael R Hayden Reports Purchase of Common Shares Worth $481,234.19

Reuters
·
Aug 14

U.S. Stocks on the MOVE-EnerSys, Netflix, Salesforce

Reuters
·
Aug 14

AbCellera Dips After $200 Mln Share Sale for Menopause Drug

Reuters
·
Aug 13

AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares

Reuters
·
Aug 13

AbCellera Prices Oversubscribed Public Offering at USD 9.75 Per Share to Raise USD 200 Million

Reuters
·
Aug 13

Abcellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants

THOMSON REUTERS
·
Aug 13

Abcellera Biologics Inc.: Pricing of Public Offering of 17,435,897 Shares at a Price of $9.75 Per Share

THOMSON REUTERS
·
Aug 13

Shares of Abcellera Biologics Down 7.9% Premarket After Launching $200 Mln Stock Offering

THOMSON REUTERS
·
Aug 12

AbCellera Biologics (ABCL) On ABCL635 Trial Results And A Richer Valuation Story

Simply Wall St.
·
Aug 12

AbCellera Biologics Launches $200 Million Public Offering

MT Newswires Live
·
Aug 12

Canada's Eupraxia Q2 Net Loss Widens on Higher R&D Costs

Reuters
·
Aug 12

AbCellera Slips After Launching $200 Mln Stock Offering to Fund Menopause Drug

Reuters
·
Aug 12

AbCellera Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Reuters
·
Aug 12

AbCellera Umumkan Penawaran Saham Lanjutan Senilai USD 200 Juta

Reuters
·
Aug 12